Intraarterial chemotherapy in Republic of Korea: Our Best Clinics and Costs 2026

Intra-arterial chemotherapy (IAC) is a targeted cancer treatment delivering high-dose medication directly into tumor-feeding arteries via a microcatheter. Surgeons in South Korea perform this 30–60 minute procedure under fluoroscopic guidance. This method maximizes drug concentration at the site while limiting systemic toxicity and side effects.

• Navigation technique: Surgeons insert microcatheters through the femoral artery using real-time angiography.
• Precise delivery: Korean centers use balloon occlusion to ensure medication stays within the tumor.
• Treatment cycles: Patients typically undergo 3–6 sessions spaced 3–4 weeks apart for efficacy.
• Post-operative care: Doctors perform daily exams and use steroid drops to manage localized inflammation.

Bookimed Expert Insight: Korea's `Big 5` hospitals like Severance Hospital specialize in superselective catheterization for pediatric retinoblastoma. Their ASIAC protocol alternates between intra-arterial and intravenous cycles. This specific rotation creates a dual-action defense that significantly increases organ salvage rates compared to single-method approaches.

Patient Consensus: Many families report less nausea compared to traditional chemo. They suggest preparing for eyelid swelling that peaks on day 3 and strictly following 48-hour groin care protocols.

Severance Hospital, Samsung Medical Center, and Seoul National University Hospital are top Korean institutions for intra-arterial chemotherapy. These facilities hold Joint Commission International (JCI) accreditation. They utilize advanced interventional radiology to treat liver cancer and retinoblastoma with high precision and fewer side effects.

• Surgeon expertise: Teams at SNUH often collaborate with U.S. specialists on complex cases.
• Clinical rankings: Samsung Medical Center ranked 3rd globally for oncology by Newsweek magazine.
• Advanced technology: Clinics use robotic delivery systems for chemotherapy not yet standard elsewhere.
• International support: Dedicated centers provide English-speaking coordinators and medical tourism visa assistance.

Bookimed Expert Insight: Severance Hospital manages a massive volume of 1.6 million outpatients annually. This high frequency creates an experience gap in rare procedures. Their oncology centers benefit from 2,000 doctors sharing data. This density often leads to faster protocol adjustments than smaller international clinics.

Patient Consensus: Patients report higher precision and fewer side effects compared to traditional treatments. Many recommend contacting international departments early to secure English-speaking coordinators for logistics.

Hepatic Arterial Infusion Chemotherapy (HAIC) in South Korea offers superior response rates and survival for advanced liver cancer. This targeted approach delivers high drug concentrations directly via the hepatic artery. It minimizes systemic toxicity and serves as an effective bridge to curative surgical resection.

• Tumor response: Achieves significantly higher objective response rates compared to standard transarterial chemoembolization.
• Survival extension: Extends median survival to 15–24 months for patients with unresectable hepatocellular carcinoma.
• Reduced toxicity: High intrahepatic uptake reduces systemic side effects like nausea and hand-foot syndrome.
• Vascular efficacy: Recommended in Korean guidelines for treating advanced cases with portal vein invasion.
• Surgical bridging: Shrinks unresectable tumors to make patients eligible for life-saving liver transplants.

Bookimed Expert Insight: While HAIC is often compared to TACE, Bookimed data shows high-volume centers like Severance Hospital prioritize it for patients with marginal liver function. Their established infrastructure for Port-a-cath systems allows for seamless repeat cycles. This expertise helps maintain a superior safety profile for complex Child-Pugh B cases.

Patient Consensus: Patients report significantly fewer systemic side effects compared to traditional IV chemotherapy. Many value how quickly the targeted delivery can shrink nodules to qualify them for surgery.

Intra-arterial chemotherapy risks include localized vascular complications like arterial spasms, thrombosis, or catheter-related occlusion. While reducing systemic exposure, patients may still experience milder nausea, fatigue, and temporary myelosuppression. Specialist clinics in Seoul utilize advanced fluoroscopy to monitor real-time drug delivery and vessel patency.

• Vascular complications: Risk of arterial narrowing, spasms, or bleeding at the catheter entry point.
• Local toxicity: Eye-specific treatments may cause eyelid swelling, ptosis, or retinal vascular narrowing.
• Infusion site pain: Patients often report burning sensations or bruising at the groin injection area.
• Systemic side effects: Milder instances of hair loss, mouth sores, and lowered white blood counts.

Bookimed Expert Insight: Data from high-volume centers like Severance Hospital shows vascular imaging is the primary safety differentiator. Top Korean oncology departments perform post-procedure angiograms after every single cycle. This immediate verification catches minor vessel narrowing before it becomes a permanent blockage or complication.

Patient Consensus: Patients emphasize that while systemic side effects are lighter than IV chemo, the localized burning sensation during infusion is intense. Many recommend advocating for slower infusion rates to manage this discomfort effectively.

Appropriate candidates for intra-arterial chemotherapy in Korea include patients with localized, arterially-supplied tumors that are resistant to systemic treatment. Clinics like Severance Hospital prioritize this for advanced liver cancer with portal vein invasion or pediatric retinoblastoma cases to avoid eye removal.

• Liver function: Candidates must maintain Child-Pugh class A or B liver function levels.
• Disease localization: Treatment requires tumors to be confined locally without significant distant metastasis.
• Retinoblastoma criteria: Children typically must weigh over 10 kg or exceed 3 months age.
• Treatment failure: Ideal for patients non-responsive to sorafenib or standard chemoembolization therapies.

Bookimed Expert Insight: Korean centers like Severance Hospital often utilize intra-arterial chemotherapy as a aggressive bridge to liver transplants. Our data shows these JCI-accredited facilities frequently recommend this approach earlier than Western protocols. This strategy aims to maximize local tumor control while minimizing systemic toxicity in cirrhotic patients.

Patient Consensus: Patients value this procedure as a vital globe-salvaging option for children. Those with liver cancer emphasize that maintaining good performance status is critical for eligibility.

Intraarterial chemotherapy in the Republic of Korea typically follows a 4-to-6 month timeline. Each session takes 45–90 minutes under light sedation. Patients usually stay 1 day in the hospital. Full visual stabilization and assessment occur between 6 and 12 months post-treatment.

• Treatment cycle: Sessions repeat every 28 days for 4–6 total cycles.
• Acute recovery: Swelling and redness peak at 48 hours and resolve within 5 days.
• Cycle downtime: Plan for 7 days of rest with eye shielding after each session.
• Long-term milestones: Vision improvements are often noticeable by the third month of treatment.

Bookimed Expert Insight: Leading Seoul centers like Severance Hospital use refined dosing to reduce systemic toxicity. Data shows these protocols often require fewer cycles than standard US treatments. This minimizes long-term side effects while maintaining high success rates for pediatric and adult patients.

Patient Consensus: Expect temporary redness and light sensitivity immediately after each infusion. Most patients find that staying strictly hydrated and tracking eye pressure daily helps manage the initial 48-hour recovery peak.

Patients choose South Korea for intra-arterial chemotherapy due to world-leading 70.4% five-year cancer survival rates and specialized expertise in salvage therapies. Facilities like Severance Hospital offer advanced superselective catheterization, reducing systemic toxicity while saving eyes in approximately 50% of advanced retinoblastoma cases.

• Cost savings: Patients typically save _price_percent_discount_% compared to US costs for advanced oncology procedures.
• Clinical infrastructure: Korea ranks 4th globally for MRI density with JCI-accredited facilities in Seoul.
• Efficiency: Diagnostic `one-stop` systems complete full treatment planning within 3 to 5 days.
• Advanced technology: Top centers integrate AI and robotic surgery within Newsweek-ranked world-best hospitals.

Bookimed Expert Insight: While many choose Korea for lower prices, the real advantage is the massive patient volume. Severance Hospital alone treats 1.6 million outpatients annually. This scale allows Korean oncology teams to refine superselective techniques faster than Western counterparts, often achieving 80% tumor shrinkage in salvage cases where other regions report only 40%.

Patient Consensus: Families highlight that Korean centers provide expert pediatric care with minimal side effects. Many report successful outcomes with no vision loss and faster hair regrowth compared to standard systemic chemotherapy.